SGX

Ultraviolet Light-Based Microbial Reduction Device For Luer-Activated Valves

产品代码
SGX
器械名称
Ultraviolet Light-Based Microbial Reduction Device For Luer-Activated Valves
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 880.6512
FDA 专业组
General Hospital
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件

FDA 分类定义

An ultraviolet light-based microbial reduction device for luer-activated valves is a device that uses ultraviolet light to irradiate luer-activated valves (e.g., as used for intravascular administration). The device is intended to supplement the manual, physical microbicidal treatment of luer-activated valves by providing limited microbial reduction, and is not intended to disinfect or replace manual microbicidal treatment.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2025-12-23。

510(k) 号批准日期申请人器械名称摘要
DEN2500042025-12-23Hai SolutionsQIKCAP System
FDA 官方分类页: SGX
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。